Perspective Therapeutics Inc
Perspective Therapeutics Inc (CATX) Covered Calls
No qualifying covered call setups were found for CATX in the prior session.
Read more
Running CATX covered calls helps you generate consistent income from Perspective Therapeutics Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Perspective Therapeutics Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best CATX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if CATX stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling CATX covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Perspective Therapeutics Inc covered call is worth writing.
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc.
in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
Income-focused investors, long-term CATX holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling CATX covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Perspective Therapeutics Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV percentile43.25% Neutral
- Market cap (M$)329
- 52 weeks high-53.25%
- 52 weeks low46.94%
- Analyst recommendationStrong Buy
1.14 - Target price$12.23
329.88% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-09
- P/E—
- Future P/E—
- EPS (ttm)-1.33
- EPS growth next 5 years12.05%
As of September 17, 2026
No illustrative rows to display.
As of September 17, 2026
Sell covered calls with the data behind you
Find the best CATX covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→